| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.0007 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |